LAB Cash Ratio
4.75TTM
Retrieved:
LAB FY Cash Ratio
5.060.00
2006-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
LAB cash ratio history
Cash divided by current liabilities. The available annual fiscal periods series contains 20 observations from Dec 31, 2006 to Dec 31, 2025.
| Period ending | Cash Ratio |
|---|---|
| 1.0915 | |
| 2.5302 | |
| 0.4729 | |
| 1.8716 | |
| 0.574 | |
| 1.2631 | |
| 0.66 | |
| 2.5385 | |
| 1.7344 | |
| 1.188 | |
| 0.968 | |
| 1.1473 | |
| 2.0444 | |
| 5.0573 | |
| 0.6719 | |
| 0.3092 | |
| 2.0483 | |
| 2.0885 | |
| 2.944 | |
| 3.499 |
Compare cash ratio
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) cash ratio
- Bridgebio Pharma Inc (BBIO) cash ratio
- Brightspring Health Services Inc (BTSG) cash ratio
- Madrigal Pharmaceuticals Inc (MDGL) cash ratio
- Ensign Group Inc (ENSG) cash ratio
- Glaukos Corp (GKOS) cash ratio
- Vaxcyte Inc (PCVX) cash ratio
- Krystal Biotech Inc (KRYS) cash ratio
Compare all covered stocks by cash ratio →
All LAB financial metrics · LAB stock overview · How to interpret financial metrics